Max Healthcare Institute: Growth Priced-In, Valuation Rich, Time for Breather.
We downgrade Max Healthcare (MAXHEALTH) to REDUCE (from ADD earlier) with a TP of INR 880, based on a 29x blended Q1FY27E EV/EBITDA (vs FY26E EV/E)
316 Views
Bumrungrad Hospital (BH TB): Record High Margins in 1Q24; Reasonable Growth in Foreign Patients
With tight cost control, Bumrungrad reported record high margins in 1Q24, with gross, EBITDA, and net margin reaching 51.7%, 40.7%, and 30.2%,...
697 Views
IHH Healthcare (IHH MK): Patient Volume Driven Revenue Growth in 4Q; Profitability Remains Subdued
IHH Healthcare reported 11% YoY revenue growth to RM5.5 billion in 4Q23, driven by higher patient volumes and revenue intensity across all...
530 Views
Max Healthcare (MAXHEALTH IN): New Hospital Acquisition Expands Footfall in a New Populus City
Max Healthcare is foraying in Lucknow by acquiring 550-bedded Sahara Hospital for INR 9.4B (~$113M). The Hospital currently serves ~2 lakh...
668 Views
Max Healthcare (MAXHEALTH IN): Robust Financial Performance in Q2; Expansion Projects Are On Track
Max Health reported Q2 revenue growth of 17% YoY and 6% QoQ to INR18.3B, driven by higher ARPOB and OBDs. EBITDA grew 21% YoY and 14% QoQ to...
646 Views